Did Not Meet Requirements
The table below provides reasons why Research Proposals have not met the requirements check carried out by Study Sponsors/Funders. More information is usually sought from requestors before the proposal is turned down.
The Research Proposal is not seeking access to anonymised patient level data
Proposal number |
Sponsor / Funder |
615 |
GSK |
618 |
GSK |
633 |
GSK |
690 |
GSK |
938 |
BI/GSK/Roche |
941 |
Roche |
1047 |
GSK |
1087 |
GSK |
1107 |
GSK |
1589 |
Novartis |
The Research Proposal did not meet the Sponsor/Funder policies for informed consent
Proposal number |
Sponsor / Funder |
931 |
BI/GSK |
The Research Proposal required data that was not collected in the studies requested
Proposal number |
Sponsor / Funder |
1552 |
Novartis |
1908 |
Lilly |
11762 |
Novartis |
The Research Proposal competes with the sponsor's publication plan
Proposal number |
Sponsor / Funder |
1235 |
BI |
1245 |
BI |
11564 |
Novartis |
11904
|
Bayer |
Sponsor doesn't have the legal authority to provide the datas
Proposal number |
Sponsor / Funder |
1751 |
Astellas |
Researcher was directed to Sponsor Clinical Study Reports to find the data requested
Proposal number |
Sponsor / Funder |
5680 |
Lilly |
The product is currently undergoing regulatory activities and data cannot be shared at this time
Proposal number |
Sponsor / Funder |
11480 |
Sanofi |
The image data requested is not in a format that can be easily anonymized
Proposal number |
Sponsor / Funder |
11231 |
Eisai |
Plans are not consistent with the requirement for any model and/or code to be published in a manner that allows their broad non-commercial use
Proposal number |
Sponsor / Funder |
12016 |
GSK |
Novartis will not share case narratives, documentation for adjudication, imaging data (e.g. x-rays, MRI scans, etc.), genetic data and exploratory biomarker data.
Proposal number |
Sponsor / Funder |
1848 |
Novartis |
It is essential for GSK that where GSK data are made available to an academic group to train an AI/ML model, the model
and code are published in a manner that allows their broad non-commercial use. Since your plans are not consistent with this requirement, GSK will not be able to agree to your request.
Proposal number |
Sponsor / Funder |
12032 |
GSK |
618 |
GSK |
633 |
GSK |
690 |
GSK |
938 |
BI/GSK/Roche |
941 |
Roche |
1047 |
GSK |
1087 |
GSK |
1107 |
GSK |
1589 |
Novartis |
Proposal number
|
Study Sponsor(s)/funder(s)
|
Reason(s)
|
615 |
GSK |
The Research Proposal is not seeking access to
anonymised patient level data |
618 |
GSK |
The Research Proposal is not seeking access to
anonymised patient level data |
633 |
GSK |
The Research Proposal is not seeking access to
anonymised patient level data |
690 |
GSK |
The Research Proposal is not seeking access to
anonymised patient level data |
931 |
BI/GSK |
The Research Proposal did not meet the Sponsor
policies for informed consent |
938 |
BI/GSK/Roche |
The Research Proposal is not seeking access to
anonymised patient level data |
941 |
Roche |
The Research Proposal is not seeking access to
anonymised patient level data |
1047 |
GSK |
The Research Proposal is not seeking access to
anonymised patient level data |
1087 |
GSK |
The Research Proposal is not seeking access to
anonymised patient level data |
1107 |
GSK |
The Research Proposal is not seeking access to
anonymised patient level data |
1552 |
Novartis |
The proposed research required data that was not collected in the studies requested |
1235 |
BI |
The Research Proposal competes with the Sponsor's publication plan |
1245 |
BI |
The Research Proposal competes with the Sponsor's publication plan |
1589 |
Novartis |
The Research Proposal is not seeking access to anonymised patient level data |